Information

You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

loading
Correction to : Results of the SEL-I-METRY Phase II Trial on Resensitization of Advanced Iodine Refractory Differentiated Thyroid Cancer to Radioiodine Therapy by Wadsley et al. Thyroid 2023;33(9):1119–1123;doi: 10.1089/thy.2022.0707